Multiplex Assays (Nucleic Acid, Protein, Cell) Market - Global Forecast to 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Multiplex Assays Market by Product, Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%

Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. However, the high cost of multiplex assay equipment & standardization of immunoassay design and quality control are the major factors expected to restrain market growth.

On the basis of end user, the global multiplex assays market is divided into pharmaceutical and biotechnology companies, hospitals & academic research institutes, reference laboratories, and other end users. In 2018, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increased adoption of multiplex assays in drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.

By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe. The dominant share of North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

The key players in the multiplex assays market are Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Multiplex Assays Market, By Product and Service

7 Multiplex Assays Market, By Type

8 Multiplex Assays Market, By Technology

9 Multiplex Assays Market, By Application

10 Multiplex Assays Market, By End User

11 Multiplex Assays Market, By Region

12 Competitive Landscape

13 Company Profiles

  • Luminex
  • Thermo Fisher Scientific
  • Illumina
  • Bio-Rad Laboratories
  • Qiagen
  • Abcam
  • Becton Dickinson and Company
  • Merck
  • Agilent Technologies
  • Meso Scale Diagnostics
  • Randox Laboratories
  • Quanterix
  • Bio-Techne
  • Olink
  • Seegene

For more information about this report visit https://www.researchandmarkets.com/research/6ljxzj/multiplex_assays?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Laboratory Equipment

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Laboratory Equipment